Neonatal drug withdrawal syndrome Active Not Recruiting Phase 3 Trials for Buprenorphine (DB00921)

Also known as: Drug withdrawal syndrome neonatal / Neonatal Abstinence Syndrome / Neonatal withdrawal symptoms from maternal use of drugs of addiction / Drug withdrawal syndrome in newborn / Withdrawal syndrome neonatal / Neonatal abstinence syndrome (disorder)

IndicationStatusPhase
DBCOND0101857 (Neonatal drug withdrawal syndrome)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03911466Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-studyTreatment
NCT03918850Medication Treatment for Opioid Use Disorder in Expectant MothersTreatment